Toronto, ON--(Marketwired - October 27, 2015) – On Monday, November 9, 2015, Xtalks will host a complimentary webinar providing an overview of the independent endpoint adjudication process with a focus on understanding what is necessary to operationalize an endpoint committee. Featured speakers include Dr. Richard Walovitch, President of WorldCare Clinical, and Dr. Glenn Bubley, Director of Genitourinary Medical Oncology at Beth Israel Deaconess Medical Center.
Over the last few years the majority of drugs approved by the FDA have been approved based on results obtained using independent adjudication committees. The data from these committees are often used to determine primary safety and efficacy endpoints and are of paramount importance to drug and device approvability. Yet little regulatory guidance is provided regarding how these committees should be designed and performed.
Besides being a mechanism to remove bias, by using integrated teams of sub-specialty trained clinical experts, independent adjudication committees may also increase the accuracy and precision of any subjective assessment. In addition, a central adjudication can provide a solution to the variability in endpoint definition based on standard of care caused by trials becoming more global and of longer duration.
During this session you will:
If you are designing trials with subjective endpoints this webinar may benefit your design. Whether you are from a biotech, pharmaceutical, or medical device company with responsibility or involvement in Clinical Operations, Project Management, Medical Affairs, Pharmacovigilance, Protocol Development, Biostatistics, or Data Management, you will come away with tools that can bring your trials greater accuracy and precision.
For more information or to register for this free webinar visit: An Overview and Guide to Clinical Trial Endpoint Adjudication
About WorldCare Clinical
WorldCare Clinical is a global imaging CRO that employs scientific expertise, innovative technology, and operational excellence to maximize the precision and accuracy of a blinded independent central review of Phase I – IV clinical trial data. The company has worked with thousands of sites in more than 60 countries. WCC’s robust technology platform processes over 250 million images annually (CT, MRI, X-Ray, Echo, US, PET). Originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology, WorldCare continues to maintain a strategic relationship with the Harvard Hospital System as well as other leading academic institutions.
For more information on WCC's services, please visit our website at wcclinical.com or contact:
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx